CoChat

Antimalarial agents: Closing the gate on toll‐like receptors?

Lafyatis, Robert, York, Michael, Marshak‐Rothstein, Ann · 2006 · Arthritis & Rheumatism
Cited by 150

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Antimalarial agents have a long history of efficacy in systemic lupus erythematosus (SLE). Initially understood to treat skin disease, they are known to also relieve arthritis and pleurisy. In addition to these therapeutic benefits, they likely have a role in prophylaxis of disease activation. Should all SLE patients be taking antimalarials? The answer to this requires more information regarding its prophylactic efficacy and is complicated by continuing concerns about retinal toxicity. The clinical use of antimalarial drugs might be significantly aided by better understanding of how they work. We will discuss here advances in several areas that provide a basis for understanding how antimalarials work in SLE and how they might be better utilized in the future. Over the last several years, a paradigm shift in understanding the importance of the innate immune system in SLE has been driven by the recognition that a class of pattern recognition receptors (PRRs), collectively known as Toll-like receptors (TLRs), likely contributes to pathogenesis. TLRs are best known for their ability to discriminate microbial macromolecules from host tissue and thereby rapidly activate the innate immune system. However, it has become increasingly apparent in recent years that select host molecules, especially nucleic acids, can serve as endogenous TLR ligands (for review, see refs. 1 and 2), perhaps promoting responses to damaged tissue (3). Notably, these receptors are harbored in intracellular compartments and therefore not normally accessible to circulating nucleic acids. However, receptors expressed by B cells (surface IgM), dendritic cells (DCs) (Fc receptor [FcR]), or other antigen-presenting cells can act as key intermedi

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/art.22157

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

Metadata

Authors
Lafyatis, R., York, M., & Marshak‐Rothstein, A.
Venue
Arthritis & Rheumatism
Publisher
Wiley
Published
2006-09-28
Volume
54
Issue
10
Pages
3068-3070
ISSN
  • 0004-3591 (ISSN-L)
  • 1529-0131
OpenAlex
W2015744687
Cited by
150
References
1
FWCI
4.18
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.